Priority Date: 16.12.11 (FR 20110061779)

COMBINATION OF A PROSTAGLANDIN RECEPTOR AGONIST AND AN MC1R RECEPTOR AGONIST FOR THE TREATMENT AND/OR PREVENTION OF PIGMENTATION DISORDERS

  • Application ID: EP12808360
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 11 - 50 employees
Company dna casalonga and partners
operating since 1867
Headquarter in Paris and 3 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Casalonga & Partners is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 16.12.2011 - Priority Date (FR 20110061779)
  • 20.06.2013 - Publication A1 (WO2013087936)
  • 22.10.2014 - Publication A1 (EP2790692)
  • 23.11.2016 - Publication B1 (EP2790692)